Newswise
forgotten login
how to register

© Newswise.
All Rights Reserved.

Source: British Medical Journal   Released: Mon 28-Jun-2004, 08:50 ET 
Embargo expired: Tue 29-Jun-2004, 18:10 ET 
Printer-friendly Version 

Effects of Passive Smoking May Have Been Underestimated

Libraries
Medical News
 Keywords
PASSIVE SMOKING UNDERESTIMATED EFFECTS

Contact Information

Available for logged-in reporters only

Description

The full effects of passive smoking may have been underestimated, according to a new study. Most studies on passive smoking have examined the risks of living with someone who smokes. Although this is an important component of exposure, it does not take account of additional exposure in workplaces and in public places.


BMJ Online First

Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement BMJ Online First

The full effects of passive smoking may have been underestimated, according to a new study available on bmj.com today (Wednesday 30 June).

Most studies on passive smoking have examined the risks of living with someone who smokes. Although this is an important component of exposure, it does not take account of additional exposure in workplaces and in public places (particularly pubs and restaurants). In contrast, cotinine (a by-product of nicotine) can provide a more accurate measure of exposure from all these sources.

Researchers at St George's Hospital Medical School and the Royal Free UCL Medical School examined the links between blood cotinine levels and risk of coronary heart disease (CHD) and stroke in 4,729 men from 18 British towns. The men were monitored for 20 years.

Higher concentrations of blood cotinine levels among the non-smokers were associated with a 50-60% greater risk of CHD. In earlier partner smoking studies, passive smoking is associated with a 25-30% increased risk. This suggests that the effects of passive smoking may have been underestimated in earlier studies, say the authors. The risks were particularly increased during the early follow up periods, indicating that the association between cotinine levels and CHD seems to decline with time. This suggests a further possible source of underestimation of the effects of passive smoking, as long follow up periods have been a feature of many earlier studies, they add.

Further studies of the association between cotinine (or similar biomarkers) and risk of CHD will help to assess the effects of passive smoking on cardiovascular disease with greater precision. In the meantime, these results should add to the weight of evidence suggesting that exposure to passive smoking is a public health hazard and should be minimised, they
conclude.

Click here to view full paper:
http://press.psprings.co.uk/bmj/june/passivesmoking.pdf